HM Payson & Co’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $9.05K | Hold |
99
| – | – | ﹤0.01% | 865 |
|
|
2024
Q4 | $8.56K | Hold |
99
| – | – | ﹤0.01% | 852 |
|
|
2024
Q3 | $9.43K | Sell |
99
-150
| -60% | -$14.3K | ﹤0.01% | 842 |
|
|
2024
Q2 | $22.8K | Hold |
249
| – | – | ﹤0.01% | 734 |
|
|
2024
Q1 | $22.6K | Hold |
249
| – | – | ﹤0.01% | 724 |
|
|
2023
Q4 | $20.3K | Hold |
249
| – | – | ﹤0.01% | 735 |
|
|
2023
Q3 | $19.9K | Buy |
249
+1
| +0.4% | +$80 | ﹤0.01% | 730 |
|
|
2023
Q2 | $19.5K | Hold |
248
| – | – | ﹤0.01% | 733 |
|
|
2023
Q1 | $19.3K | Hold |
248
| – | – | ﹤0.01% | 719 |
|
|
2022
Q4 | $19.3K | Hold |
248
| – | – | ﹤0.01% | 677 |
|
|
2022
Q3 | $17K | Hold |
248
| – | – | ﹤0.01% | 722 |
|
|
2022
Q2 | $19K | Hold |
248
| – | – | ﹤0.01% | 730 |
|
|
2022
Q1 | $20K | Hold |
248
| – | – | ﹤0.01% | 753 |
|
|
2021
Q4 | $19K | Buy |
+248
| New | +$19K | ﹤0.01% | 774 |
|